Seeking Alpha

stock-PR.com's  Instablog

stock-PR.com
Send Message
  • Galectin Therapeutics (GALT) Gets US Patent "Galactose-Prolonged Polysaccharides In A Formulation For Antifibrotic Therapies" 0 comments
    Nov 26, 2012 2:13 PM

    stockpr_logo-site

    FREE Daily Stock Alerts From Stock-PR.com

    chartstockalert

    http://static.cdn-seekingalpha.com/uploads/2012/11/26/saupload_galt.jpg GALT, Galectin Therapeutics, Inc.

    ** GALT reported that it has received a notice of allowance from the U.S. Patent and Trademark Office for a divisional patent of Patent Number 8,236,780 “Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies”.

    The patent covers key methods of derivation and use for the Company’s galactomannan-based carbohydrate galectin inhibitor compounds, for use in patients with chronic liver disease associated with the development of fibrosis, established liver fibrosis or end-stage scarring, or cirrhosis.

    Fibrotic disease of the liver is highly prevalent in the population because all chronic liver diseases, including viral hepatitis, fatty liver and alcohol abuse, result in fibrosis of the liver for which there are no currently approved pharmaceutical therapies.

    http://static.cdn-seekingalpha.com/uploads/2012/11/26/saupload_galt_chart.png

    GALT is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, key mediators of biologic function.

    More about GALT at www.galectintherapeutics.com.

    **************************************************************

    Read Full Disclaimer at http://stock-pr.com/disclaimer

    stock-pr.com/22047/stock-alerts/galectin.../

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Back To stock-PR.com's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.